Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 6.2M | Sales 2022 | 1.5M | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -25M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
-2.46% | 103B | |
+1.87% | 95.28B | |
+1.46% | 22.15B | |
-15.70% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.31% | 16.05B | |
+4.75% | 13.68B | |
+35.63% | 12.17B |